Page 52 - Aneesh Phadnis/workspace/business Standard Web/video

Network strategy: Jet's pact with Air France is not good news for Etihad

On Wednesday, Jet Airways announced a pact with Air France-KLM that will involve close collaboration among the partners on network

Ranjit Shahani steps down at Novartis after two decades

The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in Hyderabad

We are eyeing one million passengers from India in 2018, says KLM CEO

India is now the 7th largest intercontinental market for Amsterdam airport up from 12th in 2016

Lupin's profit dips 31 per cent on weak US sales

Revenue fell 7.9 per cent to Rs 3,952 crore on a year-on-year basis with weak US business contributing to the decline

Slot woes may clip wings of private planes

Delhi airport operator proposes permission system for chartered flights

Drug inventory remains below pre-GST level

A reduction in inventory level would mean lower working capital requirement

SpiceJet plane skids off Mumbai runway; passengers rescued using chutes

DGCA to inquire into the incident

Drug makers dial foreign regulators on quality issues

IPA says it is bringing industry and regulators together to address these concerns

Fosun Pharma to buy 74% stake in Gland for $1.09 billion

Agrees to cut size of stake in Hyderabad-based injectable maker to 74%, after earlier proposal to acquire 86% met approval roadblock

We expect this quarter to have good uptick for our products: GSK Pharma MD

Q&A with Annaswamy Vaidheesh, MD of GSK Pharmaceuticals India

India's Houston: Heavy rain paralyses Mumbai; flights, trains hit

Met dept records 65 mm rain in 3 hours, forecasts 'extremely heavy rainfall' in next 24 to 48 hours

Mumbai rains live: Inclement weather hits flight operations

Arriving passengers stranded as no taxis available

Jet Airways may stop first class in Boeing 777

Jet Airways has 10 Boeing 777 planes and it flies them to Amsterdam, Hong Kong and London

Sun Pharma slips to Rs 424 cr Q1 loss on weak sales, anti-trust settlement

Revenue dipped 23 per cent to Rs 6,167 crore owing to continued pricing pressure and other reasons

Shareholder activism at Alembic Pharma: Issue unlikely to die in a hurry

Alembic's board rejected the request by Unifi Capital to appoint Murali Rajagopalachari as director

Biocon cancer drug now only a step away from getting USFDA approval

The FDA is expected to take a call on approving Biocon's Trastuzumab by September 3

Tata's JV partner Singapore Airlines keen to expand network in India

In 2015, the airline launched Vistara in India along with partner Tata Sons

Air India stake sale: Traffic rights, airport slots are the biggest draws

Bidders will, however, seek clarity on debt restructuring and the level of govt control

US FDA steps add to pricing woes of pharma firms

FDA measures are part of its Drug Competition Action Plan

Drug inventory with stockists falls ahead of GST

While industry-wide average inventory is 27 days, in case of some companies it is lower than 20 days